HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hatsue Fujino Selected Research
Hatsue Fujino Research Topics
Disease
33
Hepatocellular Carcinoma (Hepatoma)
04/2022 - 12/2013
15
Neoplasms (Cancer)
08/2021 - 12/2014
10
Chronic Hepatitis C
01/2021 - 10/2014
9
Infections
02/2022 - 05/2016
8
Fibrosis (Cirrhosis)
07/2022 - 06/2015
8
Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 06/2015
6
Neoplasm Metastasis (Metastasis)
10/2021 - 12/2014
5
Liver Diseases (Liver Disease)
03/2022 - 03/2017
4
Hepatic Encephalopathy
11/2020 - 03/2018
3
Hepatitis B
01/2021 - 03/2017
3
Chronic Hepatitis B
01/2021 - 01/2018
3
Thrombosis (Thrombus)
10/2020 - 06/2015
2
Insulin Resistance
03/2022 - 12/2014
2
Fever (Fevers)
01/2021 - 03/2011
2
Necrosis
01/2021 - 01/2018
2
Hepatitis
01/2021 - 12/2018
2
Microsatellite Instability
10/2020 - 07/2020
2
Non-alcoholic Fatty Liver Disease
08/2020 - 03/2014
2
Sarcopenia
02/2020 - 03/2019
2
Edema (Dropsy)
02/2020 - 08/2016
2
Chronic Hepatitis (Chronic Active Hepatitis)
01/2020 - 12/2018
2
Disease Progression
01/2020 - 07/2019
2
Brain Diseases (Brain Disorder)
08/2019 - 07/2014
1
Fatty Liver
07/2022
1
Hyperglycemia
03/2022
1
Glucose Intolerance
03/2022
1
Hypoglycemia (Reactive Hypoglycemia)
03/2022
1
Intrahepatic Cholestasis
01/2022
1
Alcoholic Fatty Liver
07/2021
1
Diabetes Mellitus
03/2021
1
Thrombocytopenia (Thrombopenia)
03/2021
1
Lung Neoplasms (Lung Cancer)
02/2021
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021
1
Liver Failure
02/2021
1
Sclerosing Cholangitis
02/2021
1
Autoimmune Pancreatitis
01/2021
Drug/Important Bio-Agent (IBA)
12
lenvatinib
IBA
04/2022 - 08/2019
9
Antiviral Agents (Antivirals)
IBA
02/2022 - 08/2016
7
Sorafenib (BAY 43-9006)
FDA Link
01/2021 - 12/2013
7
Interferons
IBA
11/2020 - 12/2014
7
Ribavirin (Virazole)
FDA Link
Generic
01/2020 - 10/2014
4
asunaprevir
IBA
01/2020 - 08/2016
4
Biomarkers (Surrogate Marker)
IBA
01/2020 - 01/2018
4
daclatasvir
IBA
01/2020 - 08/2016
3
Bevacizumab (Avastin)
FDA Link
04/2022 - 08/2021
3
atezolizumab
IBA
04/2022 - 08/2021
3
Enzymes
IBA
02/2021 - 10/2019
3
Antigens
IBA
01/2021 - 03/2017
3
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2021 - 12/2014
3
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 03/2017
3
Hepatitis B Surface Antigens (HBsAg)
FDA Link
01/2021 - 03/2017
3
Cytokines
IBA
01/2020 - 01/2018
3
Pharmaceutical Preparations
IBA
08/2019 - 03/2011
3
telaprevir
IBA
12/2014 - 10/2014
2
Hemoglobins (Hemoglobin)
IBA
03/2022 - 11/2016
2
Glucose (Dextrose)
FDA Link
Generic
03/2022 - 03/2014
2
Immune Checkpoint Inhibitors
IBA
02/2021 - 10/2020
2
Immunoglobulins (Immunoglobulin)
IBA
01/2021 - 03/2017
2
Alanine Transaminase (SGPT)
IBA
01/2021 - 01/2018
2
regorafenib
IBA
01/2021 - 01/2021
2
Prothrombin (Factor II)
IBA
01/2021 - 12/2014
2
Fetal Proteins (Fetoprotein)
IBA
11/2020 - 01/2018
2
Proteins (Proteins, Gene)
FDA Link
11/2020 - 01/2020
2
Sofosbuvir
IBA
11/2020 - 12/2018
2
pembrolizumab
IBA
10/2020 - 07/2020
2
pibrentasvir
IBA
04/2020 - 03/2019
2
glecaprevir
IBA
04/2020 - 03/2019
2
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2020 - 05/2016
2
Chemokines
IBA
07/2019 - 01/2018
2
entecavir
FDA Link
12/2018 - 01/2018
2
HMGB1 Protein (HMG1)
IBA
01/2018 - 01/2018
1
Capsules (Microcapsules)
IBA
07/2022
1
Blood Glucose (Blood Sugar)
IBA
03/2022
1
Nonsense Codon (Nonsense Mutation)
IBA
01/2022
1
Therapeutic Uses
IBA
07/2021
1
Biological Products
IBA
06/2021
1
Circulating Tumor DNA
IBA
06/2021
1
Thrombopoietin Receptors
IBA
03/2021
1
lusutrombopag
IBA
03/2021
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
02/2021
1
Nivolumab
IBA
02/2021
1
Prednisolone (Predate)
FDA Link
Generic
02/2021
1
Ursodeoxycholic Acid (Urso)
FDA Link
Generic
02/2021
1
Pemetrexed (MTA)
FDA Link
01/2021
1
glecaprevir and pibrentasvir
IBA
01/2021
1
hepatitis B surface antigen presurface protein 1
IBA
01/2021
1
Abatacept (Orencia)
FDA Link
01/2021
1
Tyrosine Kinase Inhibitors
IBA
01/2021
1
Ramucirumab
IBA
01/2021
1
Glucocorticoids
IBA
01/2021
1
Immunoglobulin G (IgG)
IBA
01/2021
Therapy/Procedure
26
Therapeutics
10/2021 - 03/2011
7
Drug Therapy (Chemotherapy)
10/2020 - 12/2013
3
Surgical Portasystemic Shunt (Portosystemic Shunt)
08/2019 - 07/2014
2
Glycemic Control
03/2022 - 03/2014
2
Liver Transplantation
01/2021 - 03/2017
1
Fluid Therapy (Oral Rehydration Therapy)
10/2021
1
Gastrectomy
07/2021
1
Bariatric Surgery
07/2021
1
Complementary Therapies (Alternative Medicine)
01/2021